OfloxacinThird Party Manufacturing in India

Ofloxacin works by inhibiting two bacterial enzymes, DNA gyrase (topoisomerase II) and topoisomerase IV, which are essential for bacterial DNA replication, transcription, repair, and recombination.

It binds to the enzyme-DNA complex, causing DNA cleavage and leading to rapid bacterial cell death. This bactericidal effect helps the body clear systemic bacterial infections rapidly.

Unlike early-generation antibiotics, Ofloxacin offers broad-spectrum coverage against both Gram-positive and Gram-negative pathogens with excellent tissue penetration. It is highly effective for patients with severe respiratory, urinary, and skin infections.

Therapeutic Uses

Ofloxacin is prescribed for the treatment of:

• Respiratory Tract Infections: Treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia.
• Urinary Tract Infections: Treatment of uncomplicated and complicated urinary tract infections.
• Skin and Soft Tissue Infections: Treatment of uncomplicated skin and skin structure infections.
• Pelvic Inflammatory Disease: As part of combination therapy for acute pelvic inflammatory disease.

Why Manufacturers Choose Ofloxacin

Ofloxacin is a proven, highly reliable broad-spectrum antibiotic that remains a first-line treatment in many clinical scenarios. The demand for high-quality intravenous fluoroquinolones is consistently high in hospitals across the globe.

This makes Ofloxacin one of the most sought-after molecules for third party manufacturing in India, with consistent demand from hospital supply networks, PCD franchise operators, and export-oriented companies.